{"title":"How Much Can Optimization of Hypofractionation Help to Reduce Carbon Equivalent Emissions? A Single-Center Modeling Study","authors":"Dimitri Vanmarcke MD , Olena Holubowska MSc , Ate Poorthuis MSc, PhD , Bram Mangelschots MSc , Jean-François Daisne MD, PhD","doi":"10.1016/j.adro.2025.101781","DOIUrl":null,"url":null,"abstract":"<div><h3>Purpose</h3><div>Climate change poses a major threat to public health. The health care sector paradoxically contributes significantly to greenhouse gas emissions. In radiation therapy, increased hypofractionation could reduce both patient transport and linear accelerator (LINAC) use, but the size of the impact remains largely undocumented. We estimated department-wide CO<sub>2</sub> equivalent (CO<sub>2</sub>e) emissions of patient transport and LINAC energy consumption both in a real-world scenario and in a hypothetical maximized hypofractionation scenario.</div></div><div><h3>Methods and Materials</h3><div>We performed a retrospective exploratory study of all patients treated with external beam radiation therapy in 2019 (pre-COVID-19 year) at the University Hospitals Leuven (Belgium). CO<sub>2</sub>e emissions of patient transport were modeled by considering the kilometers traveled by car between the patient’s home and the hospital as well as the number of visits necessary for the treatment. Second, the hypothetical impact of implementing the most hypofractionated schedules according to the current (December 2024) best scientific evidence was calculated using the model. Finally, energy consumption of our Varian TrueBeam and Halcyon LINAC was measured to calculate the related CO<sub>2</sub>e emissions.</div></div><div><h3>Results</h3><div>In 2019, there were 43,433 patient visits over 2625 external beam radiation therapy courses with an estimated total of 2.67 million km traveled, resulting in an estimated 394 t of CO<sub>2</sub>e emissions. Implementation of hypothetical maximalized hypofractionation would decrease emissions by 18.3% (95% CI, 17.7%-20.0%) on average. The reduction was much larger for early breast cancer (–32.4%) and prostate cancer (–48.5%) than for all the other pathologies (–7.0%). Comparing a prostate treatment in 16 (<em>n</em> = 2 patients) and 5 (<em>n</em> = 2) fractions on the TrueBeam and 16 (<em>n</em> = 2) fractions on the Halcyon, energy use was, respectively, 47.1, 23.6, and 9.2 kWh over the total course, or 6.17, 3.10, and 1.21 kg of CO<sub>2</sub>e emissions.</div></div><div><h3>Conclusions</h3><div>In our hypothetical scenario, maximal optimization of hypofractionation schedules significantly reduces CO<sub>2</sub>e emissions by decreasing patient transport and, to a much lesser extent, energy consumption.</div></div>","PeriodicalId":7390,"journal":{"name":"Advances in Radiation Oncology","volume":"10 6","pages":"Article 101781"},"PeriodicalIF":2.2000,"publicationDate":"2025-04-10","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Advances in Radiation Oncology","FirstCategoryId":"1085","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S2452109425000697","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0
Abstract
Purpose
Climate change poses a major threat to public health. The health care sector paradoxically contributes significantly to greenhouse gas emissions. In radiation therapy, increased hypofractionation could reduce both patient transport and linear accelerator (LINAC) use, but the size of the impact remains largely undocumented. We estimated department-wide CO2 equivalent (CO2e) emissions of patient transport and LINAC energy consumption both in a real-world scenario and in a hypothetical maximized hypofractionation scenario.
Methods and Materials
We performed a retrospective exploratory study of all patients treated with external beam radiation therapy in 2019 (pre-COVID-19 year) at the University Hospitals Leuven (Belgium). CO2e emissions of patient transport were modeled by considering the kilometers traveled by car between the patient’s home and the hospital as well as the number of visits necessary for the treatment. Second, the hypothetical impact of implementing the most hypofractionated schedules according to the current (December 2024) best scientific evidence was calculated using the model. Finally, energy consumption of our Varian TrueBeam and Halcyon LINAC was measured to calculate the related CO2e emissions.
Results
In 2019, there were 43,433 patient visits over 2625 external beam radiation therapy courses with an estimated total of 2.67 million km traveled, resulting in an estimated 394 t of CO2e emissions. Implementation of hypothetical maximalized hypofractionation would decrease emissions by 18.3% (95% CI, 17.7%-20.0%) on average. The reduction was much larger for early breast cancer (–32.4%) and prostate cancer (–48.5%) than for all the other pathologies (–7.0%). Comparing a prostate treatment in 16 (n = 2 patients) and 5 (n = 2) fractions on the TrueBeam and 16 (n = 2) fractions on the Halcyon, energy use was, respectively, 47.1, 23.6, and 9.2 kWh over the total course, or 6.17, 3.10, and 1.21 kg of CO2e emissions.
Conclusions
In our hypothetical scenario, maximal optimization of hypofractionation schedules significantly reduces CO2e emissions by decreasing patient transport and, to a much lesser extent, energy consumption.
期刊介绍:
The purpose of Advances is to provide information for clinicians who use radiation therapy by publishing: Clinical trial reports and reanalyses. Basic science original reports. Manuscripts examining health services research, comparative and cost effectiveness research, and systematic reviews. Case reports documenting unusual problems and solutions. High quality multi and single institutional series, as well as other novel retrospective hypothesis generating series. Timely critical reviews on important topics in radiation oncology, such as side effects. Articles reporting the natural history of disease and patterns of failure, particularly as they relate to treatment volume delineation. Articles on safety and quality in radiation therapy. Essays on clinical experience. Articles on practice transformation in radiation oncology, in particular: Aspects of health policy that may impact the future practice of radiation oncology. How information technology, such as data analytics and systems innovations, will change radiation oncology practice. Articles on imaging as they relate to radiation therapy treatment.